Activation of caspases in p53-induced transactivation-independent apoptosis

Japanese Journal of Cancer Research

Volumn 90, Issue 2, 1999, Pages 180-187

  Gao, Chongfeng ^a   Tsuchida, Nobuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase; Fas; Jurkat; p53

Indexed keywords

CASPASE; CASPASE 3; CYCLOHEXIMIDE; FAS LIGAND; MUTANT PROTEIN; PROTEIN P53;

AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; TEMPERATURE SENSITIVE MUTANT; TRANSACTIVATION; WESTERN BLOTTING;

EID: 0033028457     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00731.x     Document Type: Article

References (38)

1. Green, M. S., Bennett, W. P., Hollstein, M. and Harris, C. C. Mutation in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
2. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331 (1997).
3. Ko, L. J. and Prives, C. p53: puzzle and paradigm. Genes Dev., 10, 1054-1072 (1996).
4. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, R., Parsons, R., Trent, J. M., Lin, D., Mercer, E., Kinzler, K. W. and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
5. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell, 75, 805-816 (1992).
6. Xing, Y., Hanmon, G. J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. p21 is a universal inhibitor of cyclin kinase. Nature, 366, 701-704 (1993).
7. Sabbatini, P., Lin, J., Levine, A. J. and White, E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev., 9, 2184-2192 (1995).
8. Friedlander, P., Haupt, Y., Prives, C. and Oren, M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol., 16, 4961-4971 (1996).
9. Miyashita, T. and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299 (1995).
10. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R. and Kley, N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature, 377, 646-649 (1996).
11. Caelles, C., Helmberg, A. and Karin, M. p53 dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223 (1994).
12. Haup, Y., Rowan, S., Shaulian, E., Vousden, K. H. and Oren, M. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev., 9, 2170-2183 (1995).
13. Walker, K. K. and Levine, A. J. Identification of a p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA. 93, 15335-15340 (1996).
14. Chen, X., Ko, L. J. and Prives, C. p53 level, functional domains and DNA damage determine the extent of apoptotic response of tumor cells. Genes Dev., 10, 2438-2451 (1996).
15. Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. J. and Harris, C. C. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev., 10, 1219-1232 (1996).
16. Alnemri, E., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W. and Yuan, J. Y. Human ICE/CED-3 protease nomenclature. Cell, 87, 171 (1996).
17. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyer, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. and Dixit, V. M. Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801-809 (1995).
18. Srivnivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G. and Alnemri, E. S. Molecular ordering of the Fas-apoptotic pathway: the Fas/apo-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA, 93, 14486-14491 (1996).
19. Martin, S. J. and Green, D. R. Protease activation during apoptosis: death by a thousand cuts? Cell, 82, 349-352 (1995).
20. Enari, M., Talanian, R. V., Wong, W. W. and Nagata, S. Sequential activation of ICE-like and CPP32-like protease during Fas-mediated apoptosis. Nature, 380, 723-726 (1996).
21. Geley, S., Hartmann, B. L., Hattmannstorfer, R., Loffler, M., Ausserlechner, M. J., Bernhard, D., Sgonc, R., Strasser-Wozak, E. M. C., Ebner, M., Auer, B. and Kofler, R. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM. Oncogene, 15, 2429-2437 (1997).
22. Sabbatini, D., Han, J., Chiou, S. K., Nicholson, D. W. and White, E. Interleukin 1β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ., 8, 643-653 (1997).
23. Lotem, J. and Sachs, L. Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis. Proc. Natl. Acad. Sci. USA, 94, 9349-9353 (1997).
24. Yamato, K., Yamamoto, M., Hirano, Y. and Tsuchida, N. A human temperature-sensitive p53 mutant p53 val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. Oncogene, 11, 1-6 (1995).
25. Fuchs, E. J., Mckenna, K. A. and Bedi, A. p53-dependent DNA damage-induced apoptosis requires Fas/apo-1-independent activation of CPP32b. Cancer Res., 57, 2550-2554 (1997).
26. Soussi, T., Fromentel, C. C. and May, P. Structural aspects of p53 protein in relation to gene evolution. Oncogene, 5, 945-952 (1990).
27. Gong, J., Traganos, F. and Darzynkiewilz, Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem., 218, 314-319 (1994).
28. Nagata, S. Apoptosis by death factor. Cell, 88, 355-365 (1997).
29. Friesen, C., Herr, I., Krammer, P. H. and Debatin, K. M. Involvement of the CD95(Apo-1/Fas)receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2, 574-577 (1996).
30. Fulda, S., Sieverts, H., Friesen, G., Her, I. and Debatin, K. M. The CD95(Apo-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res., 57, 3823-3829 (1997).
31. Hueber, A., Zornig, M., Lyon, D., Suda, T., Nagata, S. and Evan, G. Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis. Science, 278, 1305-1308 (1997).
32. Wang, J. F. Analysis of downstream effectors of p53 on cell growth arrest and apoptosis induced by a temperature-sensitive Va1138 mutant. J. Med. Dent. Sci., 45, 141-149 (1998).
33. Hall, A. R. and Milner, J. Structural and kinetic analysis of p53-induced DNA complexes and comparison of human and murine p53. Oncogene, 10, 561-567 (1995).
34. Lane, D. P., Stephen, C. W., Midgley, C. A., Sparks, A., Hupp, T. R., Daniels, D. A., Greaves, R., Reid, A., Vojtesek, B. and Picksley, S. M. Epitope analysis of the murine p53 tumor suppressor protein. Oncogene, 12, 2461-2466 (1996).
35. Salvesen, G. and Dixit, V. M. Caspase: intracellular signaling by proteolysis. Cell, 9, 443-446 (1997).
36. Li, H., Bergeron, L., Cryns, N., Pasternack, M. S., Zhu, H., Shi, L., Greenberg, L. and Yuan, J. Activation of caspase-2 in apoptosis. J. Biol. Chem., 272, 21010-21017 (1997).
37. Yin, Y., Terauchi, Y., Solomon, G. G., Aizawa, S., Rangarajan, P. N., Yazaki, Y., Kadowaki, T. and Barrett, J. C. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature, 391, 707-710 (1998).
38. Villunger, A., Egle, A., Kos, M., Hartmann, B. L., Geley, S., Kofler, R. and Greil, R. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res., 57, 3331-3334 (1997).